Estimation Levels of Cholecystokinin, Gastrin and Secretin in Patients With Type 2 Diabetes Mellitus

Abstract

A diabetic patient with diabetes mellitus experiences high blood sugar levels as a result of low insulin levels or a resistance to the medication's effects. The tests were carried out at a medical laboratory using specialized kits, and the 45 patient samples and 45 healthy person samples from both sexes as a control group were dispersed based on the questionnaire form. In contrast to the non-significant rise in serum gastrin and secretin levels, the results demonstrated a substantial increase in cholecystokinin (CCK) levels between the patient and control groups and a significant increase in CCK levels according to gender, type of therapy, and disease history. In conclusion, individuals with diabetes mellitus type 2 may have aberrant blood CCK levels, which require concentration to assess the full scope of their impact on the individual.